×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 9: FDA's Actions on the Original IND and Future Amendments
Session Chair(s)
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- FDA’s Review of an IND
- Clinical Holds: Basis for Imposition and Process for Removal